Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro does not come in a traditional syringe. It is supplied as a pre-filled KwikPen — each pen contains four weekly doses of tirzepatide, the dual GIP and GLP-1 receptor agonist licensed in the UK for weight management. Clinical trials published in the New England Journal of Medicine showed average body-weight reductions of around 20–21% over 72 weeks at the highest dose, and those results were achieved with the injector pen used at home, once a week. Mounjaro is a prescription-only medicine, so a prescriber must assess whether it is clinically suitable for you before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Every participant in SURMOUNT-1 (the landmark tirzepatide weight-management trial) used the same KwikPen format that reaches UK patients today. The trial ran for 72 weeks across more than 2,500 adults and the results (roughly 20–21% average weight loss at 15 mg) were achieved by people self-injecting once a week at home, not in a clinical setting. That context matters: the pen was deliberately designed so that patients could use it reliably without nursing support. The NHS medicines page for tirzepatide confirms the injection method and covers the main safety points clearly.
Treatment starts at 2.5 mg (a tolerability dose that allows the body to adjust) and is titrated in steps by the prescriber, typically every four weeks, up through 5, 7.5, 10, 12.5, and 15 mg. Each pen corresponds to one strength, so patients move to a new pen when their dose changes. There is no measuring, no drawing up of liquid, and no separate plunger to manage.
This design is part of why adherence in the trials held up well. The weekly schedule, combined with a device that requires minimal technique, removes many of the practical barriers that older injectable therapies carried.
A question our prescribers hear most weeks is whether Mounjaro needs a separate needle or comes ready to inject. The answer is that a needle is attached immediately before each use (it screws onto the pen's tip) and then removed and disposed of in a sharps container straight afterwards. Leaving a needle attached between doses risks contamination and can let air into the mechanism.
The actual injection sequence is short: attach a new needle, prime as instructed in the leaflet, choose a clean injection site, pinch the skin gently if you find that helpful, press the pen against the skin until you hear a click, and hold it in place for around ten seconds. The pen does the rest. No plunger, no manual force. You can find full technique guidance in the Patient Information Leaflet included with your pen, or on the eMC (electronic Medicines Compendium), where the Mounjaro SmPC is published in full.
Rotating between the abdomen, thigh, and upper arm is important. Using the same spot repeatedly can cause skin changes (thickening or lumping) that affect how quickly tirzepatide is absorbed. A simple pattern (left abdomen, right abdomen, left thigh, and so on) makes rotation easy to remember without writing anything down.
The KwikPen is kept in the fridge between 2 °C and 8 °C. Because Mounjaro is taken once a week, most people keep the current pen in the fridge door and inject on the same day each week, then order the next pen in good time. Detailed guidance on storing Mounjaro covers what to do if the pen warms up, how long a room-temperature window is permitted, and why the pen should never be frozen, the SmPC is the authoritative reference for exact figures and should always be consulted rather than relying on memory.
Travelling is generally straightforward. The pen travels in its original carton; airline rules allow medication in hand luggage with a prescription. A small cool bag with an ice pack keeps the pen within the safe temperature range on longer journeys. For shorter domestic trips where a fridge will be available at the destination, most patients find the transition seamless enough with a little advance planning.
Some people ask whether they can switch between pen strengths mid-pack, or use part of one pen and keep the rest. The answer is no, each pen is designed for single-patient use across the four doses at that strength, and each dose uses a fresh needle. Unused doses left in a discarded pen are wasted, which is one reason prescribers give careful thought to timing dose changes at the right point in the pack cycle.
If you are considering Mounjaro for weight management and have practical questions about the pen before you start, that conversation belongs in your clinical consultation. Details such as which injection sites work best for your lifestyle, whether you have any anxiety around needles, or how to handle a missed dose are all things the prescriber will want to cover. Patients based in the East Midlands can also read about how we support people through our Mounjaro service in Nottingham, which explains local access and what to expect from an in-person consultation. For a broader look at how tirzepatide fits into a weight-management plan, the weight-loss treatments overview is a useful starting point.
There are also questions that sit alongside the pen itself, and if you take over-the-counter painkillers regularly, our page on how tirzepatide and aspirin interact addresses one of the more frequent queries we receive. Pricing context is covered separately; if you want to understand what the cost of private treatment typically includes, the Mounjaro cost and access page sets that out plainly. Start your free consultation with our prescribers whenever you are ready.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.